Skip to main navigation
  • News & Investors

    News & Investors

    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact
  • Contact Us
Celsion
  • TECHNOLOGY
    • LTSL
    • TheraPlas
    • TheraSilence
  • PRODUCTS
    • ThermoDox
    • GEN-1
  • PIPELINE
    • Clinical Studies
    • Pre-clinical Programs
  • DISEASES
  • PUBLICATIONS
  • ABOUT US
    • Leadership
    • Board of Directors
    • Corporate Governance
Select Page

Scientific Presentations

    Investor Relations

    • News & Investors
    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact

Scientific Presentations

Scientific Presentations
Mar 30, 2021
Poster Presentation at Society of Gynecologic Oncology (SGO) Virtual Annual Meeting on Women’s Cancer_March 19-26, 2021
View Presentation 634.4 KB
Aug 8, 2019
Expert Call – Ovarian Cancer Treatment Landscape and Emerging Opportunities Oppenheimer & Co. Inc. Conference Call
View Presentation 6.5 MB
Mar 4, 2019
Presentation at the ASCO-SITC Clinical Immuno-Oncology Symposium Entitled “Phase I study of IL-12 plasmid administered in combination with NAC in patients with advanced stage ovarian cancer” by Dr. Premal H. Thaker, M.D., M.S.
View Presentation 1.5 MB
Oct 22, 2018
Publication in Future Oncology – GEN-1 immunotherapy for the treatment of ovarian cancer, Premal H. Thaker, Nicholas Borys, Jason Fewell & Khursheed Anwer
View Publication 3.4 MB
Apr 12, 2018
Presentation at a company-sponsored Symposium- “Emerging Horizons in HCC: From Palliation to Cure” – at the International Liver Congress ™ 2018 entitled “Rethinking Our Approach to Intermediate-Size HCC” By Prof. Riccardo Lencioni, M.D., FSIR, EBIR.
View Presentation 5.5 MB
Mar 1, 2018
KoL Lunch Presentation by Dr. Premal Thaker titled “Ovarian Cancer: New Horizons and Treatments”
View Presentation 18 MB
Oct 2, 2017
Presentation at the American Association of Cancer Research (AACR) Special Conference entitled "Addressing Critical Questions in Ovarian Cancer Research and Treatment" by Dr. Khursheed Anwer, Celsion's executive vice president and chief scientific officer
View Poster 1.4 MB
Feb 23, 2017
Presentation at the American Society of Clinical Oncology (ASCO) - Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Symposium by Khursheed Anwer, Ph.D. (Celsion's executive vice president and chief science officer) entitled "Phase I st
View Poster - Abstract #156 267.6 KB
Feb 23, 2017
Presentation at the American Society of Clinical Oncology (ASCO) - Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Symposium by Khursheed Anwer, Ph.D. (Celsion's executive vice president and chief science officer) entitled "Immunologic
View Poster - Abstract #155 244.8 KB
Nov 28, 2016
Presentation at the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, IL by Dr. Haydar Celik, Ph.D. (NIH Clinical Center) entitled "RFA Duration per Tumor Volume May Correlate With Overall Surviva
View Presentation 1.3 MB
Oct 29, 2016
Presentation at the 3rd Asian Conference on Tumor Ablation (ACTA) in Seoul, Korea by Professor Won Young Tak, M.D., Ph.D. entitled "Thermo-Sensitive Drug Assisted Ablation.
View Presentation 1.2 MB
Apr 18, 2016
Presentation at the 2016 American Association of Cancer Research (AACR) Annual Meeting during the Drug Delivery Session by Dr. Jason Fewell entitled "Interlukin-12 Gene therapy in Combination with Bevacizumab and PEGylated Liposomal Doxorubicin for Treatm
View Presentation 885.6 KB
Dec 14, 2015
Presentation at the 2015 San Antonio Breast Cancer Symposium during the New Drugs and Treatment Strategies Session by Dr. Hope Rugo entitled Lyso-Thermosensitive Liposomal Doxorubicin Shows Efficacy with Minimal Adverse Events in Patients with Breast Canc
Report 447.2 KB
Nov 2, 2015
Presentation Abstracts and Oral Presentation from the 2015 Asian Conference on Tumor Ablation (ACTA) in Fukuoka, Japan on October 30-31, 2015
View Abstract 9.8 KB
View Abstract 9.8 KB
Oral presentation 1.1 MB
Sep 5, 2015
Presentation at the International Liver Cancer Association 2015 Annual Conference on September 5, 2015 by Professor Riccardo Lencioni entitled "OPTIMA Phase III Clinical Trial: Study Design and Protocol."
View Presentation 1.5 MB
Sep 5, 2015
Presentation at the International Liver Cancer Association 2015 Annual Conference on September 5, 2015 by Dr. Ronnie T.P. Poon entitled ""Current Management of Intermediate HCC: Unmet Medical Needs."
View Presentation 2.1 MB
Sep 5, 2015
Presentation at the International Liver Cancer Association 2015 Annual Conference on September 5, 2015 by Dr. Ghassan K. Abou-Alfa entitled "Intermediate HCC Treatment Paradigms and Lessons Learned."
View Presentation 749.8 KB
Jun 1, 2015
A Phase I Study of Intraperitoneal EGEN-001 (IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer) Administered in Combination with Pegylated Liposomal Doxorubicin) in Patients with Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Pr
Report 215.5 KB
Feb 20, 2015
Presentation at the Molecular Medicine TRI-Conference on February 20, 2015 by Dr. Khursheed Anwer titled "Development of a Novel IL-12 DNA-based Immunotherapy in Combination with Chemotherapy for Treatment of Advanced Ovarian Cancer."
Report 1.3 MB
Sep 6, 2014
Presentation at the International Liver Cancer Association 2014 Annual Conference on September 6, 2014 by Dr. Richard Finn titled "Phase III Studies in Intermediate Stage HCC: What Have We Learned From Recent Failures"
Report 3.9 MB
Sep 6, 2014
Presentation at the International Liver Cancer Association 2014 Annual Conference on September 6, 2014 by Professor Ronnie T.P. Poon titled "New Paradigms in Staging HCC: BCLC vs. Hong Kong Liver Cancer Staging System (HKLS)"
Report 2.2 MB
Sep 6, 2014
Presentation at the International Liver Cancer Association 2014 Annual Conference on September 6, 2014 by Professor Riccardo Lencioni titled "Image Guided Ablations: Current Status and Future Prospects"
Report 2.7 MB
Apr 9, 2014
Presentation at the 14th Annual Symposium on Therapeutic Ultrasound in Las Vegas, NV on April 5, 2014 by Dr. Mark Dewhirst – "Use of Thermosensitive Liposomes in Combination with Ultrasound"
Report 4.9 MB
Dec 12, 2013
Novel Targeted Therapy for Breast Cancer Chest Wall Recurrence Poster Presentation by Prof Hope S. Rugo, MD at the 2013 San Antonio Breast Cancer Conference.
Report 1.1 MB
Sep 16, 2013
Presentation at the 2013 International Liver Cancer Association (ILCA) Conference on September 14, 2013 by Professor Ronnie T.P. Poon, MD, PhD.
Report 747.4 KB
Jun 20, 2013
Presentation at The European Conference on Interventional Oncology (ECIO) by Professor Riccardo Lencioni, MD "New IO Approaches for HCC: An Update on Clinical Trials"
Report 1.2 MB
Jun 20, 2013
Presentation at The European Conference on Interventional Oncology (ECIO) by Professor Riccardo Lencioni, MD New Horizons: Thermally Sensitive Doxorubicin Carriers
Report 745.8 KB
May 16, 2013
Presentation at the World Conference on Interventional Oncology (WCIO) By Professor Riccardo Lencioni, MD "Advances in Image-Guided Ablation"
View Presentation 979.7 KB
Sep 17, 2012
Presentation at the 2012 Annual Congress of the Cardiovascular and Interventional Radiological Society of Europe by Professor Ronnie T.P. Poon "Thermosensitive Liposome in Combination with Thermal Ablation"
View Presentation 1.5 MB

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • Downloads
    • RSS
    • Print
    • Search

    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS

Home

Technology

Products

Pipeline

Disease

Publications

News & Investors

About Us

Careers

Privacy Policy

    ThermoDox is a registered trademark of Celsion Corporation.
    TheraPlas and TheraSilence are trademarks of Celsion Corporation.
    Avastin is a registered trademark of Genentech, Inc.
    Copyright © 2021 Celsion Corporation. All rights reserved.

    Share This
    • Twitter
    • Google+
    • Facebook
    • LinkedIn